Dealmaking is in style again under President Donald Trump. Potential takeover targets include C3.ai, Viking Therapeutics, and ...

The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with a CAGR of 6.9%. Driven by ongoing health challenges, emerging trends ...

AbbVie, Gilead Sciences and GSK marked World Hepatitis Day on Monday, outlining the need to tackle the stigma and discrimination associated with the group of viruses to eliminate them as a public ...

NEW YORK] Pheton Holdings, a Nasdaq-listed Chinese health care company, lost 90 per cent of its market value in a matter of ...

Once touted as a potential powerhouse treatment for a variety of inflammatory conditions, Galapagos’ JAK inhibitor Jyseleca ...

The COVID pandemic likely began when the virus jumped from animals to humans, and didn’t start in a lab. But false narratives ...

NEW YORK] Pheton Holdings, a Nasdaq-listed Chinese health care company, lost 90 per cent of its market value in a matter of ...

BMO Capital keeps an Outperform rating Gilead (GILD) after the Wall Street Journal reported that Robert F. Kennedy Jr. plans ...

Trading was halted at least eight more times during the course of the trading session as Pheton Holdings shares extended ...

Capitalize on the S&P 500 uptrend with momentum ETFs. See here to know why SPMO and MTUM ETFs outperform VFMO ETF for ...